Short-term Price Target Projections for Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT)

Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) shares currently have a consensus target price of $175.6. The highest target price according to data provided by Zacks Research is presently $332. The analyst with the lowest target projection on the stock sees the price reaching  $60. Target price projections may vary between covering analysts.  

No Data